Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Cardiovascular readmissions and excess costs following percutaneous coronary intervention in patients with chronic kidney disease: Data from a large multi-centre Australian registry

    Access Status
    Fulltext not available
    Authors
    Ariyaratne, T.
    Ademi, Z.
    Duffy, S.
    Andrianopoulos, N.
    Billah, B.
    Brennan, A.
    New, G.
    Black, A.
    Ajani, A.
    Clark, D.
    Yan, B.
    Yap, C.
    Reid, Christopher
    Date
    2013
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Ariyaratne, T. and Ademi, Z. and Duffy, S. and Andrianopoulos, N. and Billah, B. and Brennan, A. and New, G. et al. 2013. Cardiovascular readmissions and excess costs following percutaneous coronary intervention in patients with chronic kidney disease: Data from a large multi-centre Australian registry. International Journal of Cardiology. 168 (3): pp. 2783-2790.
    Source Title
    International Journal of Cardiology
    DOI
    10.1016/j.ijcard.2013.03.128
    ISSN
    0167-5273
    School
    Department of Health Policy and Management
    URI
    http://hdl.handle.net/20.500.11937/18729
    Collection
    • Curtin Research Publications
    Abstract

    Background: Chronic kidney disease (CKD) is a well-established risk factor for adverse events in patients undergoing percutaneous coronary intervention (PCI). However, few data exists on the subsequent healthcare resource use and related incremental costs in this patient subgroup. The present study compares the rates of cardiac-related hospitalisations and the associated direct costs, post-PCI in patients with and without CKD. Methods: Healthcare costs were estimated for 12,998 PCI patient-procedures from the Melbourne Interventional Group (MIG) registry, collected between February 2004 and October 2010. Information collected included the use of cardiovascular drugs and cardiac-related hospitalisations from those that completed 12-month follow-up. Individual patients were assigned unit costs based on published data from the National Hospital Cost Data Collection for Admissions in Victoria (2008–2009) and the Pharmaceutical Benefit Scheme (PBS) schedule (2011–2012). Bootstrap multiple linear regression was used to estimate the direct excess healthcare costs, adjusting for age and gender and relevant comorbidities. Results: Excess cardiac-related readmissions occurred among patients with “severe CKD or dialysis” (estimated glomerular filtration rate (eGFR): < 30 ml/min/1.73 m2; n = 330; 35%), compared to “moderate CKD” (eGFR: 30–60 ml/min/1.73 m2; n = 2648; 28%), or the “referent CKD status” (eGFR: ≥ 60 ml/min/1.73 m2; n = 10,020; 24%). On average, excess (95%CI) overall direct costs were significantly higher in patients with severe CKD or dialysis compared to those with referent CKD status [$AUD 2206 ($AUD 1148 to 3688)]. Conclusions: From the healthcare payer's perspective, PCI patients with severe CKD compared to no-CKD imposed significantly higher burden on subsequent healthcare resources. Hospitalisations accounted for the majority of these expenditures.

    Related items

    Showing items related by title, author, creator and subject.

    • The cost of diabetes and obesity in Australia
      Lee, Crystal; Goode, B.; Nørtoft, E.; Shaw, J.; Magliano, D.; Colagiuri, S. (2018)
      © 2018, © 2018 Informa UK Limited, trading as Taylor & Francis Group. Aims: To assess and compare the direct healthcare and non-healthcare costs and government subsidies by body weight and diabetes status. Methods: The ...
    • The cost of diabetes in adults in Australia
      Lee, Crystal; Colagiuri, R.; Magliano, D.; Cameron, A.; Shaw, J.; Zimmet, P.; Colagiuri, S. (2013)
      Aims: To assess and compare costs associated with diabetes and lesser degrees of glucose intolerance in Australia. Methods: The Australian Diabetes, Obesity and Lifestyle study collected data on the use of health services ...
    • Cost-effectiveness of artemisinin-naphthoquine versus artemether-lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children
      Moore, Brioni; Davis, W.; Clarke, P.; Robinson, L.; Laman, M.; Davis, T. (2017)
      © 2017 The Author(s). Background: A recent randomized trial showed that artemisinin-naphthoquine (AN) was non-inferior to art emether-lumefantrine (AL) for falciparum malaria and superior for vivax malaria in young Papua ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.